2023年2月23日 |
03:00 下午 - 03:45 下午 Eastern Standard Time |
Join us for our next edition of Fast Break, where we discuss clinical trial and personalized medicine developments for 2023 and the US Food and Drug Administration’s response to these matters.
As medical technologies have evolved, new opportunities have developed for healthcare entities to become further involved in product development and production. However, with new opportunities comes new regulatory considerations and risks.
Partner Jacqueline R. Berman and associate Alexandre Gapihan will take a look at some of the innovative ways companies are conducting clinical trials and making advances in medicine.
Don't forget you can view any of our previous webinars on our Fast Break series page >>